Nearly 25% of Americans Not Interested in Taking a Coronavirus Vaccine

Epoch Times

Health Secretary Alex Azar described the deal as a "major milestone" in US President Donald Trump's program to fast-track a Covid-19 vaccine, dubbed Operation Warp Speed.

The drugmaker said it has signed first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses of the potential vaccine, which it is developing with Oxford University.

A Phase I/II clinical trial of AZD1222 began last month to assess safety, immunogenicity and efficacy in over 1,000 healthy volunteers aged 18 to 55 across several trial centres in southern England.

The British company also said in a statement that it expects to be able to deliver a billion doses of the potential vaccine this year and next, if tests are successful.

The Department of Health and Human Services is working to secure 300 million doses of a new coronavirus vaccine, but a recent poll shows about a quarter of Americans aren't interested in being inoculated.

Experts like Lawrence Young, a professor of molecular oncology at the University of Warwick, said the development was important in planning for the equitable supply of the vaccine throughout the world.

The US government has secured almost one third of the anticipated production of a vaccine for coronavirus under development by AstraZeneca, after pledging more than $1 billion to fund the project. In animal tests, all the monkeys injected with the vaccine ended up testing positive for Covid-19 after being introduced to the virus. "We believe that together we will be in a strong position to start immunizing against coronavirus once we have an effective approved vaccine", John Bell, a professor of medicine at Oxford, said in a statement.

"These results support further development of ShaCoVacc as a candidate vaccine for Covid-19", the researchers wrote in the study, which has not yet been peer reviewed.

Epoch Times

Scientists have warned that a coronavirus vaccine, if developed, might not confer full immunity, while Prime Minister Boris Johnson has warned that a vaccine might never be found.

More than five million have been infected globally by the pandemic, sparking a rush by pharmaceutical companies across the world to try to develop treatments and vaccines.

Pascal Soriot, the chief executive of AstraZeneca, said: "This pandemic is a global tragedy and it is a challenge for all of humanity".

He meanwhile thanked "the USA and United Kingdom governments for their substantial support to accelerate the development and production of the vaccine".

"We are so proud to be collaborating with Oxford University to turn their ground-breaking work into a medicine that can be produced on a global scale".

"Expenses to progress the vaccine are anticipated to be offset by funding by governments", the company said.

As Covid-19 spreads around the world, it can be daunting keeping up with the information.



Other news